Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Importance of Population-Wide Studies in Controlling Noncommunicable Diseases: Achievements of Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute



Azadnajafabad S1 ; Moghaddam SS1 ; Mohammadi E1 ; Rezaei N1 ; Rezaei N1 ; Naderimagham S1 ; Haghshenas R1 ; Ghasemi E1 ; Farzi Y1 ; Abdolhamidi E1 ; Fateh SM1 ; Zokaei H1 ; Kazemi A1 ; Tabatabaeimalazy O1 Show All Authors
Authors
  1. Azadnajafabad S1
  2. Moghaddam SS1
  3. Mohammadi E1
  4. Rezaei N1
  5. Rezaei N1
  6. Naderimagham S1
  7. Haghshenas R1
  8. Ghasemi E1
  9. Farzi Y1
  10. Abdolhamidi E1
  11. Fateh SM1
  12. Zokaei H1
  13. Kazemi A1
  14. Tabatabaeimalazy O1
  15. Farzadfar F1
  16. Larijani B1
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Diabetes and Metabolism Published:2021

Abstract

Non-Communicable Diseases (NCDs) are the major cause of premature death and disability due to diseased globally, imposing a heavy burden on the health systems. Four main categories of NCDs are cardiovascular diseases, neoplasms, diabetes, and chronic respiratory diseases. Iran, the second greatest country in the Middle East Region, has been through an important transition period of communicable diseases toward NCDs in the last decades. One of the effective approaches to control NCDs is implementation of populationbased studies and interventions, trying to reduce risk factors and incidence of NCDs through investigations in the populations. Endocrinology and Metabolism Research Institute (EMRI) and Non-Communicable Diseases Research Center (NCDRC) are the pioneers trying to study and control various NCDs during the last decades in Iran. In this review, we are going to inspect some of the major completed and ongoing projects of this research institute to highlight valuable efforts to reduce burden of NCDs in Iran, and make a successful example for national and regional public health policy makers and authorities. © 2021, Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
2. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
3. National and Subnational Burden of Stroke in Iran From 1990 to 2019, Annals of Clinical and Translational Neurology (2022)
4. Protocol Design for Surveillance of Risk Factors of Non–Communicable Diseases During the Covid-19 Pandemic: An Experience From Iran Steps Survey 2021, Archives of Iranian Medicine (2022)
5. A Machine Learning Approach to Evaluate the State of Hypertension Care Coverage: From 2016 Steps Survey in Iran, PLoS ONE (2022)
6. Risk of Incident Cardiovascular Diseases at National and Subnational Levels in Iran From 2000 to 2016 and Projection Through 2030: Insights From Iran Steps Surveys, PLoS ONE (2023)
7. A Nationwide Study of Metabolic Syndrome Prevalence in Iran; a Comparative Analysis of Six Definitions, PLoS ONE (2021)
8. The First Nationally and Sub-Nationally Representative Non-Communicable Diseases Cohort Study in Iran: Iran Cohort Study (Ics) Protocol, Journal of Diabetes and Metabolic Disorders (2023)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (46)
Bagher Larijani (30)
Other Related Docs
9. Geographical, Gender and Age Inequalities in Non-Communicable Diseases Both at National and Provincial Levels in Iran, Journal of Diabetes and Metabolic Disorders (2021)
10. Association Between Being Metabolically Healthy/Unhealthy and Metabolic Syndrome in Iranian Adults, PLoS ONE (2022)
11. A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran, International Journal of Cardiology (2023)
12. Prevalence of Plasma Lipid Abnormalities and Associated Risk Factors Among Iranian Adults Based on the Findings From Steps Survey 2021, Scientific Reports (2023)
13. Inequalities in the Prevalence, Diagnosis Awareness, Treatment Coverage and Effective Control of Diabetes: A Small Area Estimation Analysis in Iran, BMC Endocrine Disorders (2023)
14. Burden of Non-Communicable Diseases in Iran: Past, Present, and Future, Journal of Diabetes and Metabolic Disorders (2020)
15. Current Inequities in Smoking Prevalence on District Level in Iran: A Systematic Analysis on the Steps Survey, Journal of Research in Health Sciences (2022)
16. Motivating Non-Physician Health Workers to Reduce the Behavioral Risk Factors of Non-Communicable Diseases in the Community: A Field Trial Study, Archives of Public Health (2023)
17. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
18. The Levels and Trends of Cancer Incidence in the Elderly Population at National and Sub-National Scales in Iran From 1990 to 2016, Cancer Reports (2024)
19. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
20. Iran to Achieve the Sdg 3.4 at National and Sub-National Levels, Scientific Reports (2022)
21. Trend and Projection of Mortality Rate Due to Non-Communicable Diseases in Iran: A Modeling Study, PLoS ONE (2019)
22. The Level and Trend of Road Traffic Injuries Attributable Mortality Rate in Iran, 1990–2015: A Story of Successful Regulations and a Roadmap to Design Future Policies, BMC Public Health (2021)
23. Prevention and Control of Non-Communicable Diseases in Iran: The Case for Investment, BMC Public Health (2022)
24. Trend of Nutrition Research in Endocrine Disorders, Gaps, and Future Plans: A Collection of Experiences of an Endocrinology Research Institute, Journal of Diabetes and Metabolic Disorders (2021)
25. The Risk and Added Values of the Atherosclerotic Cardiovascular Risk Enhancers on Prediction of Cardiovascular Events: Tehran Lipid and Glucose Study, Journal of Translational Medicine (2021)
26. The Global Spine Care Initiative: Model of Care and Implementation, European Spine Journal (2018)
27. Association of Plasma Acylcarnitines and Amino Acids With Hypertension: A Nationwide Metabolomics Study, PLoS ONE (2023)
28. Evaluation of the Diabetes Care Cascade and Compliance With Who Global Coverage Targets in Iran Based on Steps Survey 2021, Scientific Reports (2023)
29. Assessing the Effect of Socioeconomic Factors on Prevalence of Dyslipidemia Among Iranian Adult Population; District Level Analysis From 2016 Steps National Study Using Small Area Estimation, Journal of Diabetes and Metabolic Disorders (2022)
30. Patterns of Obesity and Overweight in the Iranian Population: Findings of Steps 2016, Frontiers in Endocrinology (2020)
31. Utilization Trend of Parenteral Antidiabetic Drugs in Type 2 Diabetic Patients Covered by Iran Health Insurance Organization From 2011 to 2030, Iranian Journal of Public Health (2023)
32. Iran Quality of Care in Medicine Program, a Gateway to Collecting Healthcare Data in the Absence of Nationwide Digitized Health Information, Archives of Iranian Medicine (2023)
33. Disparities and Spatial Variations of High Salt Intake in Iran: A Subnational Study of Districts Based on the Small Area Estimation Method, Public Health Nutrition (2021)
34. Insight Into Blood Pressure Targets for Universal Coverage of Hypertension Services in Iran: The 2017 Acc/Aha Versus Jnc 8 Hypertension Guidelines, BMC Public Health (2020)
35. The Burden of Metabolic Risk Factors in North Africa and the Middle East, 1990–2019: Findings From the Global Burden of Disease Study, eClinicalMedicine (2023)
36. Implication for Prevention and Control of Cardiovascular Disease; an Experience From Iran, Scientific Journal of Kurdistan University of Medical Sciences (2021)
37. Estimates of Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years of Lung Cancer in Iran, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, Cancer Medicine (2022)
38. Population Attributable Fraction Estimates of Cardiovascular Diseases in Different Levels of Plasma Total Cholesterol in a Large-Scale Cross-Sectional Study: A Focus on Prevention Strategies and Treatment Coverage, Journal of Diabetes and Metabolic Disorders (2020)
39. Prevalence of Tobacco Use in Adults; 2016 Nationally Representative Household Survey in Iran, International Journal of Preventive Medicine (2022)
40. Tobacco Consumption Patterns Among Iranian Adults: A National and Sub-National Update From the Steps Survey 2021, Scientific Reports (2023)
41. Is Salt Intake Reduction a Universal Intervention for Both Normotensive and Hypertensive People: A Case From Iran Steps Survey 2016, European Journal of Nutrition (2020)
42. Factors Influencing Health Promoting Behaviours in Women of Reproductive Age in Iran: Based on Pender’S Health Promotion Model, Open Access Macedonian Journal of Medical Sciences (2019)
43. Intersectoral Collaboration in the Management of Non-Communicable Disease’S Risk Factors in Iran: Stakeholders and Social Network Analysis, BMC Public Health (2022)
44. National and Subnational Trends in Incidence and Mortality of Lung Cancer in Iran From 1990 to 2016, Asia-Pacific Journal of Clinical Oncology (2020)
45. Recent Cancer Incidence Trends and Short-Term Predictions in Golestan, Iran 2004–2025, Cancer Epidemiology (2020)
46. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)
47. The Association Between the Nordic-Style Diet Score and Metabolic Syndrome and Obesity in Tehranian Adults, Nutrition Today (2021)
48. Patient Experience With Chronic Obstructive Pulmonary Disease: A Nationally Representative Demonstration Study on Quality and Cost of Healthcare Services, Frontiers in Public Health (2023)
49. Cohort Profile: The Fasa Adults Cohort Study (Facs): A Prospective Study of Non-Communicable Diseases Risks, International Journal of Epidemiology (2023)
50. Effectiveness of an Individualized Internet-Based Physical Activity Program: A Randomized Controlled Trial, European Journal of Integrative Medicine (2021)